Pfizer Beats Sales and Profit Forecasts, Mum on Future Deals
Pfizer Inc (PFE.N) reported stronger-than-expected quarterly results, helped by growing sales of its cancer drugs…
Pfizer-Astrazeneca Impasse Has Wall Street Baffled By U.K. Rules
The U.K.’s updated Takeover Code was supposed to make acquisitions of British companies more transparent. Instead,…
Pfizer $117 Billion Astrazeneca Hunt Said Likely To Fail
Pfizer Inc. (PFE)’s 69.4 billion-pound ($117 billion) pursuit of British drugmaker AstraZeneca Plc (AZN) is likely…
Pfizer Boss Enters Lion’s Den of UK Politics to Sell Astrazeneca Deal
The boss of U.S. drugmaker Pfizer faces UK lawmakers on Tuesday with a promise and a threat - to protect British…
Pfizer says AstraZeneca Takeover Would Benefit Science
Pfizer (PFE.N) sought to allay fears that its proposed $106 billion takeover of AstraZeneca (AZN.L) would deal a…
Pfizer says AstraZeneca Takeover Would Benefit Science
Pfizer (PFE.N) sought to allay fears that its proposed $106 billion takeover of AstraZeneca (AZN.L) would deal a…
AstraZeneca Rejects Pfizer’s Raised Bid of $106 billion
U.S. drugmaker Pfizer Inc increased its offer for AstraZeneca Plc to 63 billion pounds ($106 billion) on Friday,…
Astrazeneca: Pfizer Made No Specific Merger Offer
AstraZeneca PLC said Monday it didn't receive a specific acquisition proposal from Pfizer Inc. PFE +0.13%, and…
Pfizer Steps up $100 Billion Bid for Astrazeneca
Pfizer Inc. confirmed Monday that it made a renewed approach to AstraZeneca PLC regarding a takeover valued at…
Pfizer: Egypt Expels Pharmaceutical Investments
Dr Mohamed Swelim, Director of Business Development and Strategic Planning, Pfizer Egypt, has stated that Egypt…
